NAXITAMAB

NAXITAMAB was reported 250 times

NAXITAMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTI-MOUSE ANTIBODY POSITIVE 2 0.1176
1 NEUROBLASTOMA RECURRENT 8 0.0394
2 NEUROBLASTOMA 6 0.0157
3 SERUM SICKNESS-LIKE REACTION 3 0.0048
4 SUPERIOR MESENTERIC ARTERY SYNDROME 1 0.0045
5 PERIPHERAL VEIN THROMBOSIS 1 0.0042
6 RESPIRATORY TRACT OEDEMA 3 0.0040
7 PROLONGED EXPIRATION 1 0.0038
8 URETERIC STENOSIS 3 0.0037
9 REFRACTION DISORDER 1 0.0034
10 GASTROENTERITIS ROTAVIRUS 1 0.0032
11 HEART SOUNDS ABNORMAL 2 0.0027
12 LARYNGOSPASM 5 0.0019
13 MYELITIS TRANSVERSE 2 0.0014
14 ANTIBODY TEST ABNORMAL 1 0.0014
15 BRONCHOSPASM 18 0.0013
16 ANTIBODY TEST POSITIVE 2 0.0012
17 UPPER AIRWAY OBSTRUCTION 1 0.0011
18 MICROANGIOPATHY 1 0.0011
19 STRIDOR 3 0.0010
20 APPLICATION SITE PAPULES 1 0.0009
21 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 9 0.0009
22 PNEUMONIA STREPTOCOCCAL 1 0.0009
23 DEAFNESS NEUROSENSORY 3 0.0009
24 HYPORESPONSIVE TO STIMULI 1 0.0009
25 PULMONARY TOXICITY 6 0.0008
26 STREPTOCOCCAL SEPSIS 1 0.0008
27 PNEUMONIA INFLUENZAL 1 0.0008
28 GASTROINTESTINAL TOXICITY 4 0.0008
29 FEBRILE CONVULSION 1 0.0008
30 DRUG SPECIFIC ANTIBODY 1 0.0007
31 HYDRONEPHROSIS 5 0.0007
32 SUSPECTED OFF LABEL USE 3 0.0007
33 PNEUMONIA LEGIONELLA 1 0.0006
34 METABOLIC ALKALOSIS 1 0.0006
35 DYSPHORIA 3 0.0006
36 DEAFNESS BILATERAL 1 0.0006
37 AMYLASE INCREASED 2 0.0005
38 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
39 BLADDER SPASM 1 0.0005
40 MULTI-ORGAN DISORDER 1 0.0005
41 LIVEDO RETICULARIS 1 0.0005
42 VASCULAR DEVICE INFECTION 2 0.0004
43 HYPOXIA 15 0.0004
44 PRURITUS GENITAL 1 0.0004
45 BREATH SOUNDS ABNORMAL 2 0.0004
46 BEHAVIOUR DISORDER 2 0.0004
47 PERIORBITAL SWELLING 2 0.0004
48 RESPIRATORY SYMPTOM 1 0.0004
49 LIP PAIN 1 0.0003
50 RALES 2 0.0003
51 HYPERCAPNIA 1 0.0003
52 HYPOTENSION 66 0.0003
53 LARYNGEAL OEDEMA 2 0.0003
54 RESPIRATORY RATE DECREASED 1 0.0003
55 STUPOR 1 0.0003
56 ANAPHYLACTIC SHOCK 8 0.0003
57 OXYGEN SATURATION DECREASED 17 0.0003
58 NEPHRITIS 1 0.0003
59 TACHYPNOEA 4 0.0003
60 RESPIRATION ABNORMAL 2 0.0003
61 MYELODYSPLASTIC SYNDROME 4 0.0003
62 BLINDNESS TRANSIENT 2 0.0003
63 HAEMODYNAMIC INSTABILITY 2 0.0003
64 RHINOVIRUS INFECTION 1 0.0003
65 MYELOSUPPRESSION 9 0.0002
66 LIP OEDEMA 1 0.0002
67 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
68 RETINAL DETACHMENT 2 0.0002
69 NEPHROPATHY 2 0.0002
70 PULSE ABSENT 1 0.0002
71 HYPOVOLAEMIC SHOCK 1 0.0002
72 THROMBOTIC MICROANGIOPATHY 2 0.0002
73 ANAPHYLACTIC REACTION 11 0.0002
74 NEUTROPHIL COUNT INCREASED 2 0.0002
75 DEAFNESS 5 0.0002
76 FULL BLOOD COUNT ABNORMAL 2 0.0002
77 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
78 URTICARIA 31 0.0002
79 MYOCARDITIS 2 0.0002
80 ORTHOSTATIC HYPOTENSION 3 0.0002
81 HYPOVOLAEMIA 1 0.0002
82 TACHYCARDIA 15 0.0002
83 FEBRILE NEUTROPENIA 11 0.0002
84 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
85 MYDRIASIS 2 0.0002
86 HYPERTENSION 33 0.0002
87 CORONAVIRUS INFECTION 1 0.0002
88 URINARY RETENTION 5 0.0001
89 ECCHYMOSIS 1 0.0001
90 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
91 HYPOPHOSPHATAEMIA 1 0.0001
92 APNOEA 1 0.0001
93 ACUTE MYELOID LEUKAEMIA 2 0.0001
94 CYANOSIS 2 0.0001
95 METABOLIC ACIDOSIS 4 0.0001
96 NEURALGIA 3 0.0001
97 LIP SWELLING 4 0.0001
98 ANURIA 1 0.0001
99 COLD SWEAT 2 0.0001
100 ANGIOEDEMA 5 0.0001
101 HAEMOLYTIC ANAEMIA 1 0.0001
102 ANAL INCONTINENCE 1 0.0001
103 PALLOR 3 0.0001
104 PNEUMONITIS 3 0.0001
105 RESPIRATORY DISTRESS 3 0.0001
106 MENTAL STATUS CHANGES 3 0.0001
107 ERYTHEMA MULTIFORME 1 0.0001
108 BLOOD PRESSURE DECREASED 7 0.0001
109 HAEMATOTOXICITY 1 0.0001
110 PAIN 64 0.0001
111 GLAUCOMA 2 0.0001
112 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
113 CYTOKINE RELEASE SYNDROME 2 0.0001
114 FULL BLOOD COUNT DECREASED 2 0.0001
115 HYPERBILIRUBINAEMIA 1 0.0001
116 SWOLLEN TONGUE 3 0.0001
117 PETECHIAE 1 0.0001
118 DECREASED ACTIVITY 1 0.0001
119 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
120 MALNUTRITION 1 0.0001
121 RASH PAPULAR 2 0.0001
122 HYPONATRAEMIA 5 0.0001
123 SHOCK 2 0.0001
124 EYELID OEDEMA 1 0.0001
125 MUSCLE RIGIDITY 1 0.0001
126 PYREXIA 27 0.0001
127 RHINORRHOEA 5 0.0001
128 SARS-COV-2 TEST POSITIVE 1 0.0001
129 BLINDNESS 3 0.0001
130 NEUTROPHIL COUNT DECREASED 3 0.0001
131 IMPAIRED GASTRIC EMPTYING 1 0.0001
132 ABDOMINAL PAIN 17 0.0001
133 PERIPHERAL COLDNESS 1 0.0001
134 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
135 PANCYTOPENIA 4 0.0001
136 LYMPHOPENIA 1 0.0001
137 SINUS TACHYCARDIA 1 0.0001
138 RESPIRATORY FAILURE 5 0.0001
139 ARRHYTHMIA 3 0.0001
140 RASH 27 0.0001
141 FACE OEDEMA 1 0.0001
142 CANDIDA INFECTION 1 0.0001
143 NEOPLASM PROGRESSION 2 0.0001
144 EOSINOPHILIA 1 0.0001
145 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
146 LEUKOCYTOSIS 1 0.0001
147 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
148 RESTLESSNESS 2 0.0001
149 HYPERSENSITIVITY 10 0.0001
150 PHOTOPHOBIA 1 0.0001
151 BLOOD SODIUM DECREASED 1 0.0001
152 WHEEZING 3 0.0001
153 ABNORMAL BEHAVIOUR 2 0.0001
154 HEART RATE INCREASED 5 0.0001
155 COUGH 14 0.0000
156 TASTE DISORDER 1 0.0000
157 HYPOACUSIS 2 0.0000
158 INFUSION RELATED REACTION 3 0.0000
159 TRANSAMINASES INCREASED 1 0.0000
160 HEPATOTOXICITY 1 0.0000
161 THROMBOCYTOPENIA 5 0.0000
162 THROAT IRRITATION 2 0.0000
163 HYPOKALAEMIA 2 0.0000
164 SEIZURE 5 0.0000
165 PERICARDIAL EFFUSION 1 0.0000
166 NEUROPATHY PERIPHERAL 4 0.0000
167 BLOOD PRESSURE FLUCTUATION 1 0.0000
168 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
169 PNEUMONIA ASPIRATION 1 0.0000
170 HALLUCINATION 3 0.0000
171 HAEMATEMESIS 1 0.0000
172 FLUSHING 4 0.0000
173 UNRESPONSIVE TO STIMULI 1 0.0000
174 GASTRITIS 1 0.0000
175 BRADYCARDIA 2 0.0000
176 NEUTROPENIA 5 0.0000
177 RENAL IMPAIRMENT 3 0.0000
178 LIVER FUNCTION TEST ABNORMAL 1 0.0000
179 DYSPHONIA 2 0.0000
180 NASAL CONGESTION 2 0.0000
181 OFF LABEL USE 29 0.0000
182 FEELING HOT 2 0.0000
183 SWELLING FACE 2 0.0000
184 VIRAL INFECTION 1 0.0000
185 HAEMATURIA 1 0.0000
186 DELIRIUM 1 0.0000
187 HEART RATE DECREASED 1 0.0000
188 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
189 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
190 VOMITING 13 0.0000
191 C-REACTIVE PROTEIN INCREASED 1 0.0000
192 INTESTINAL OBSTRUCTION 1 0.0000
193 BLOOD PRESSURE INCREASED 4 0.0000
194 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
195 CHILLS 3 0.0000
196 CARDIO-RESPIRATORY ARREST 1 0.0000
197 PULMONARY OEDEMA 1 0.0000
198 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
199 OROPHARYNGEAL PAIN 2 0.0000
200 DECREASED APPETITE 5 0.0000
201 COGNITIVE DISORDER 1 0.0000
202 PRODUCTIVE COUGH 1 0.0000
203 DYSPNOEA 11 0.0000
204 ABDOMINAL PAIN UPPER 4 0.0000
205 INFLAMMATION 1 0.0000
206 PARAESTHESIA 3 0.0000
207 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
208 ASTHMA 2 0.0000
209 ANXIETY 5 0.0000
210 DISEASE PROGRESSION 2 0.0000
211 IRRITABILITY 1 0.0000
212 PLEURAL EFFUSION 1 0.0000
213 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
214 CHEST PAIN 3 0.0000
215 VISUAL IMPAIRMENT 2 0.0000
216 ANAEMIA 3 0.0000
217 NEOPLASM MALIGNANT 1 0.0000
218 SOMNOLENCE 3 0.0000
219 BURNING SENSATION 1 0.0000
220 SKIN BURNING SENSATION 1 0.0000
221 AGITATION 1 0.0000
222 HYPOAESTHESIA 2 0.0000
223 ACUTE KIDNEY INJURY 2 0.0000
224 DRUG INTERACTION 2 0.0000
225 CARDIAC FAILURE 1 0.0000
226 CARDIAC ARREST 1 0.0000
227 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
228 PRODUCT USE ISSUE 2 0.0000
229 DYSPEPSIA 1 0.0000
230 SYNCOPE 1 0.0000
231 CHEST DISCOMFORT 1 0.0000
232 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
233 HAEMORRHAGE 1 0.0000
234 PLATELET COUNT DECREASED 1 0.0000
235 PNEUMONIA 3 0.0000
236 INFLUENZA 1 0.0000
237 NAUSEA 7 0.0000
238 MUSCULAR WEAKNESS 1 0.0000
239 HEADACHE 5 0.0000
240 PRURITUS 3 0.0000
241 HYPERHIDROSIS 1 0.0000
242 FATIGUE 6 0.0000
243 RENAL FAILURE 1 0.0000
244 VISION BLURRED 1 0.0000
245 PAIN IN EXTREMITY 2 0.0000
246 PERIPHERAL SWELLING 1 0.0000
247 CONFUSIONAL STATE 1 0.0000
248 DRUG INEFFECTIVE 8 0.0000
249 ABDOMINAL DISCOMFORT 1 0.0000
250 TOXICITY TO VARIOUS AGENTS 1 0.0000
251 COVID-19 1 0.0000
252 MUSCLE SPASMS 1 0.0000
253 ERYTHEMA 1 0.0000
254 CONSTIPATION 1 0.0000
255 BACK PAIN 1 0.0000
256 DIZZINESS 2 0.0000
257 WEIGHT DECREASED 1 0.0000
258 DIARRHOEA 2 0.0000
259 FALL 1 0.0000
260 ARTHRALGIA 1 0.0000